Iron Deficiency Anemia Workup and Treatment
The initial workup for iron deficiency anemia should include serum ferritin (using a cutoff of 45 ng/mL for diagnosis), complete blood count, and screening for celiac disease, followed by bidirectional endoscopy for men and postmenopausal women with newly diagnosed IDA. 1
Diagnostic Criteria
Iron deficiency anemia is diagnosed when:
- Hemoglobin is below the lower limit of normal for the relevant population (<12 g/dL for women, <13 g/dL for men) 1, 2
- Serum ferritin is <45 ng/mL (AGA recommended cutoff) 1, 2
- Transferrin saturation is <20% 2
Additional laboratory findings may include:
- Elevated total iron binding capacity (TIBC)
- Low serum iron
- Microcytic, hypochromic red blood cells
Initial Workup
Laboratory testing:
- Complete blood count
- Serum ferritin
- Transferrin saturation
- Serum iron and TIBC
Screening for celiac disease:
- Serological testing (found in 3-5% of IDA cases) 1
- Small bowel biopsy at time of gastroscopy if serology positive
Urinalysis/urine microscopy to rule out hematuria 1
Endoscopic evaluation:
Treatment Algorithm
First-line treatment: Oral iron supplementation
For patients with oral iron intolerance or poor response:
Intravenous iron indications:
Monitoring Response to Treatment
- Check hemoglobin after 2-4 weeks of treatment (good response: Hb rise ≥10 g/L within 2 weeks) 1, 2
- Check ferritin and transferrin saturation after 4-8 weeks of treatment
- Target values: ferritin >30 μg/L and transferrin saturation >16% 2
- Continue monitoring iron parameters every three months for one year after normalization 2
Special Considerations
- Premenopausal women: If heavy menstrual bleeding is the likely cause, gynecological evaluation may be needed
- Persistent or recurrent IDA: Consider small bowel evaluation (capsule endoscopy) if bidirectional endoscopy is negative 1
- Inflammatory conditions: Higher ferritin cutoffs may be needed for diagnosis as ferritin is an acute phase reactant 1, 2
- Pregnant women: Higher iron requirements; may need 30-120 mg/day oral iron supplements 2
Pitfalls to Avoid
- Inadequate investigation: Failure to investigate the underlying cause of IDA, especially in men and postmenopausal women where GI malignancy is a concern
- Premature cessation of therapy: Iron therapy should continue for 3 months after normalization of parameters
- Misinterpreting ferritin levels: Ferritin is an acute phase reactant and may be falsely normal in inflammatory states
- Overlooking celiac disease: Always screen for celiac disease in patients with IDA
- Checking iron studies too soon after IV iron: Wait at least 4 weeks after IV iron administration before rechecking iron studies 1
By following this systematic approach to diagnosis and treatment, iron deficiency anemia can be effectively managed while identifying and addressing the underlying cause.